Sergey Klimenko leaves Pepeliaev Group
Sergey Klimenko, the partner who headed the life sciences practice at Pepeliaev Group, is leaving the firm as of 14 June. Alexander Panov has been appointed to head the practice, overseen by partner Ilya Bolotnov.
“During the time that he has worked at Pepeliaev Group, Sergey has progressed from an associate to a partner,” the firm's managing partner, Sergey Pepeliaev, said of these latest events. “He has achieved impressive results in developing the firm’s capability in the area of pharmaceuticals. But things never stand still in life. I am certain that this decision will not obstruct Sergey from continuing to develop professionally, and nor will it prevent our practice group from growing and strengthening in future.”
It is worth remembering that the life sciences practice at Pepeliaev Group is the strongest on the Russian legal market. The team currently comprises nine lawyers, who have in-depth expertise in the sector and formidable experience of providing legal services to manufacturers of medicines and medical devices, as well as to other players on the healthcare market. Pepeliaev Group is the only national law firm to claim the top ranking (Band 1) in the life sciences category of the Chambers & Partners ratings. As a result, all legal assignments entrusted to Pepeliaev Group will, as before, continue to be resolved to the highest professional standards, with the maximum effectiveness and efficiency.
The life sciences practice will continue to handle integrated projects working together seamlessly with other divisions within Pepeliaev Group, our antitrust, customs, and intellectual property practices among them.
Pepeliaev Group's team extends its sincere good wishes to Sergey for every success in his future endeavours.
“During the time that he has worked at Pepeliaev Group, Sergey has progressed from an associate to a partner,” the firm's managing partner, Sergey Pepeliaev, said of these latest events. “He has achieved impressive results in developing the firm’s capability in the area of pharmaceuticals. But things never stand still in life. I am certain that this decision will not obstruct Sergey from continuing to develop professionally, and nor will it prevent our practice group from growing and strengthening in future.”
It is worth remembering that the life sciences practice at Pepeliaev Group is the strongest on the Russian legal market. The team currently comprises nine lawyers, who have in-depth expertise in the sector and formidable experience of providing legal services to manufacturers of medicines and medical devices, as well as to other players on the healthcare market. Pepeliaev Group is the only national law firm to claim the top ranking (Band 1) in the life sciences category of the Chambers & Partners ratings. As a result, all legal assignments entrusted to Pepeliaev Group will, as before, continue to be resolved to the highest professional standards, with the maximum effectiveness and efficiency.
The life sciences practice will continue to handle integrated projects working together seamlessly with other divisions within Pepeliaev Group, our antitrust, customs, and intellectual property practices among them.
Pepeliaev Group's team extends its sincere good wishes to Sergey for every success in his future endeavours.